Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26771114.
- Also identified by DOI 10.1016/j.cmet.2015.12.012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Type 2 diabetes (T2D) is associated with dysbiosis of the gut microbiota, though diabetes treatment regimens, including metformin, may confound the results. Forslund et al. (2015) identify distinct disease and drug signatures and highlight the importance of adjusting for treatment when investigating how T2D influences the human gut microbiome.
Medical subject headings
- Diabetes Mellitus, Type 2
- Gastrointestinal Microbiome
- Metformin